LymphoSign
About:
LymphoSign Inc., is a Toronto-based drug developer.
Website: https://lymphosign.com/
Top Investors: VenGrowth Asset Management, GeneChem
Description:
LymphoSign is a pharmaceutical company that is focused on the development of drugs for blood cancers. LymphoSign was acquired by Aegera Therapeutics in August 2007. LymphoSign was founded in 2000 and is based in Markham, Canada.
Total Funding Amount:
$5.9M
Headquarters Location:
Markham, Ontario, Canada
Founded Date:
2000-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2003-07-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai